Introduction
Age-related diseases like cardiovascular disease or cancer are on a constant rise as an implication of the demographic change. As the number of active implantable medical devices (AIMDs) like cardiovascular implantable electronic devices (CIED), i.e. implantable cardiac pacemakers (ICP) and implantable cardioverter-defibrillators (ICD) increases as well as the number of diagnostics or treatments using radiation, so does also the chance of coincidence. In more and more cases, active implants are inside or close to planning target volume (PTV) in radiation therapy. As it is known that radiation can impair electronic circuits it might cause temporary or permanent damage to active implants and therefore poses an incalculable risk for the patient [1] . A first DEGRO/DKG directive on this subject was published in 2015 by Gauter-Fleckenstein et al. [2] . Also, the Task Group 34 report, the Heart Rhythm Society and the Dutch society of radiotherapy and oncology give recommendations on how to manage patients with CIEDs in radiotherapy [3] . Some case reports and only few studies have addressed this problem scientifically, none of them in a systematic way, which is likely due to the difficulty of creating a suitable test environment [4, 5, 6] . Therefore, the aim of this study was to create a tissue-equivalent test environment of the human torso, which is suitable for testing the functionality of AIMDs, as administered in a standard clinical setup. Such a test-environment needs to fulfill three major requirements: First, all materials used to surrogate human tissue need to have tissue-equivalent properties in terms of interaction with ionizing radiation like radiation scatter. Secondly, the test environment needs to provide the possibility to integrate AIMDs at the typical implantation site. Third and most important, the testenvironment should facilitate the full chain of treatment in radiotherapy with X6 photons, which means that the treatment planning process should be feasible as with a patient and the planned and applied dose have to the comparable.
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Many patients in radiotherapy carry active implantable medical devices (AIMDs) such as pacemakers or cardioverter defibrillators (ICDs). The influence of the ionizing radiation can lead to failures in the device function. This study presents a tissue-equivalent test environment to investigate the influence of ionizing radiation on AIMDs. The in-vitro test environment is designed to simulate a human torso. Structures such as the heart, lungs, ribs, spinal column and soft tissue are replicated from tissue-equivalent materials to allow realistic treatment planning and to simulate the effect of ionizing radiation on active implants. CT measurements and Monte-Carlo validations have shown that Polytetrafluorethylen (bone), carrageenan (heart), Styrodur (lung) and Biresin® G27 (soft tissue) fulfill all requirements for suitable tissue surrogates. A plug-in unit integrated in the test environment has been designed specifically to allow the placement AIMDs in the phantom at typical positions for implant placement in humans. The dosimetry validation showed that the test environment is applicable in the full treatment planning process. 
Keywords

Material evaluation and validation
The test environment should mimic the upper human torso. Therefore, organ structures such as heart, lungs, ribs, spinal column and soft tissue have to replicated from tissue-equivalent materials to allow realistic treatment planning and to simulate the effect like scattering of ionizing radiation on active implants. Material evaluation of different pre-selected materials (see Suppl. 1) was performed by comparing the Hounsfield Units (HU) in CT scans of the material samples and the human thorax. Three clinical CT scans (Somaton Emotion, Siemens Healthcare GmbH, Erlangen, Germany) of the human thorax and the material samples were randomly chosen to determine the reference HU. All clinical CT scans were performed at 120 kV, 160 mAs with a slice thickness of 3 mm. Different ROIs of 30x30 pixels were placed in spine, ribs, heart, lungs, and soft tissue in one transversal slice of each scan. Within these ROIs the mean and standard deviation of the HUs were determined. Further concerns regarded homogeneity and isotropy, antimicrobial properties, mechanical stability for shaping the required organic forms and the handling of contemplable materials. Additionally, availability and price had to be taken into consideration.
Monte-Carlo simulations for material validation were performed using PENELOPE/PENEPMA. Human tissues, as well as possible substitutes, were simulated using their respective atomic composition and density as stated in the ICRU 44 report [7] . For the simulation the radiation beam was positioned along the z-axis, pointing in (0,0,-1)-direction and perpendicular to the sample surface. Beam energy ranged from 10 keV to 6 MeV with a Gaussian cross-section. Tissue structures were compared to their substitutes in regard to generation of Bremsstrahlung and scattered photons at the substances' surface.
The integrated plug-in unit (IPU)
To provide the possibility of integrating dosimeters and AIMDs, the active implantable medical device integration plug-in unit (AIMD-IPU) was developed and placed at the physiological position of typical pacemaker or defibrillator implants.
The IPU (Figure 1 ) is firmly fixed in the soft tissue material and consists of a plug-in box and a plug-in-tube. Dosimeters, implants and electronic components can be placed in the plugin box via the integration port. The plug-in box is a 20x10x5 mm cuboid, made of acryl glass which features negligible radiation-attenuation. The plug-in tube allows to lead pacemaker electrode cables and dosimetry equipment from the main body of the active device to the heart. The plug-in tube has a diameter of 10mm and is made of EPDM rubber (ethylene propylene diene monomer). EPDM was evaluated to have low attenuation of ionizing radiation and a low friction coefficient which simplifies the insertion of electrode cables and dosimetry equipment.
Feasibility of the full chain of treatment
Based on CTs of the test environment (120kV, slice resolution = 3mm) a VMAT-plan was created using Pinnacle3 9.8 as a treatment planning system (TPS). The PTV was placed in the lung hilum because this body part is often involved in the radiation treatment planning and it is also close to AIMDs. The plug-in box containing a pacemaker was considered as an organ at risk (OAR) and therefore particularly spared as it is often performed in patient treatment planning to reduce the implant dose. The irradiation was fractionated realistically in 13 fractions with an applied dose of 4 Gy per fraction. The implant receives a mean dose of about 600 cGy. The created treatment pan and the corresponding dose-volume-histogram (DVH) is visualized in Suppl. 2. Irradiation was performed using a Synergy LINAC (Elekta, Stockholm, Sweden) and 6MeV photons. The planned dose at a manually defined dose measurement point near the heart was validated by a 0.125 cm³ semiflex ionization chamber (PTW, Freiburg, Deutschland) which can be placed using the plug-in tube. The measured dose was compared to the planned dose after fraction 6, 7, 8, 11, 13 for five irradiation measurements. 
Results
Development of the test-environment
Material evaluation and validation
For modelling soft tissue, Biresin® G27, a two component Polyurethane resin system, fulfils all criteria and was chosen as model material. Best properties for modelling lung tissue were provided by Styrodur (BASF 3000 C), usually used as insulating material in construction. The selection criteria of the heart were closely matched by a combination of 3.5% (m/m) carrageenan and 96.5% (m/m) H2O. A small amount (spade point) of NaN3 was added to ensure resistance against microbial colonization. Dense and stable plastics fulfil all criteria to form bones, but only Polytetrafluorethylen (PTFE) matched the organic tissue in terms of HU values, while Polyethylen (PE)-1000 and Polystyrol (PS) have significantly different absorption properties. Hence PTFE was used to form spine and ribs. Suppl. 1 provides a detailed compilation of the material evaluation. The results from the CT measurements are also confirmed by Monte-Carlo simulations. Figure 2 shows this exemplarily for heart and bone tissue and their possible surrogates. The probability density for the generated Bremsstrahlung and scattered photons in the energy range from 10 keV to 1 MeV, for 6 MeV photons. It can be seen that the carrageenan-based and agarose-based heart tissue surrogate approaches fit best. Additionally, Figure 2 visualizes that PTFE is the best material to surrogate bone, as the probability density for generated Bremsstrahlung and scattered photons is the closest to bone out of the simulated materials. The attenuation is material dependent in the energy range of the photo-effect. For higher energies (> 1 MeV), the dominating attenuation is always becoming more independent of the material properties.
All anatomic structures were first formed separately out of the best fitting materials and then combined into a compact body (Figure 3 ). The spinal column and ribs were designed using CATIA V5R20 (Dassault Systèmes). To generate the geometry of the lunges, a patient data set in the radiation treatment planning system (Pinnacle3 9.8, Philips Radiation Oncology) was used. The lung was contoured and converted into a triangle mesh-structure. Matlab (R2017a) was utilized to generate a STL-file from the 3D-meshed Pinnacle data. The spinal column, ribs and the lobes of the lungs were all processed using 6-axis milling. The heart was shaped by casting the liquid gelmixture into a mould. The two components of Biresin® G27 were combined to form the phantom layer by layer while placing the different tissue structures in their appropriate locations. The resin is casted in a cylindrical sheet shape, functioning as a casting mould which holds the structure together until the resin is hardened. After the casting process the sheet shape was removed.
Feasibility of the full chain of treatment
The dose verification near the heart after fraction 6, 7, 8, 11, 13 showed a good agreement with an overall deviation of ~ 2% (for five irradiation measurements) from the planned to the measured dose (Figure 4) .
A CT scan of the resulting test environment for final verification with patient data and quality control of the anatomical arrangement of the structures and the AIMD-IPU is shown in 
Discussion and Conclusion
In this study tissue-equivalent materials were found for all major anatomical structures in the thorax. CT scans and MonteCarlo simulations of the chosen materials verified the equivalence in terms of Hounsfield Units. As these are a direct measure from radiation absorption and commonly used in radiation treatment planning, materials with similar HU values can be expected to interact with radiation in the same way. While phantoms have been widely used in radiation therapy [8] , it is still necessary to construct specialized phantoms for the purpose to investigate the functionality of AIMDs and electronic components exposed to scatter radiation during radiotherapy.
The novel IPU provides the necessary feature to investigate the influence of ionizing radiation on such AIMDs. Therefore, the developed test environment provides the essential basis for a future standardized and reproducible investigation. In future studies this will help to investigate the effect of radiation on such devices and to formulate regulations for a safe treatment of all patients.
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